Retraction Note: GDF11 enhances therapeutic functions of mesenchymal stem cells for angiogenesis

Chi Zhang, Yinuo Lin, Ke Zhang, Luyang Meng, Xinyang Hu, Jinghai Chen, Wei Zhu, Hong YuStem 2023 · DOI · OpenAlex

Introduction

In 2021, a study titled "GDF11 enhances therapeutic functions of mesenchymal stem cells for angiogenesis" was published in the journal Stem Cell Research & Therapy. The research aimed to investigate how Growth Differentiation Factor 11 (GDF11) might improve the regenerative and angiogenic capabilities of mesenchymal stem cells (MSCs). However, following concerns regarding data integrity, the authors have formally retracted the article. This note outlines the reasons for the retraction and its implications for the scientific record.

Summary of the Original Research

The original publication focused on the therapeutic potential of MSCs in regenerative medicine, particularly for treating ischemic diseases. The authors hypothesized that GDF11 could act as a potent enhancer of MSC function, specifically promoting angiogenesis—the process of new blood vessel formation. To support these claims, the study utilized various cell biology techniques, including imaging of cell behavior, Western blotting for protein expression (such as the anti-apoptotic marker Bcl-2), and flow cytometry for cell population characterization.

Reasons for Retraction

The retraction was necessitated by several significant errors discovered in the presentation and analysis of the data. According to the formal notice, the authors identified the following issues:

Image Duplication and Recycling

The most pervasive issue involved "image duplication errors" across multiple figures, including Figures 2A, 5K, 6B, S3E, and S10B. The authors admitted that some of these images were not only duplicated within the manuscript but were also recycled from their own earlier work published in the Journal of Cellular and Molecular Medicine in 2020. This overlap suggests a failure in the rigorous screening of visual data during the manuscript's preparation.

Technical and Analytical Errors

Beyond visual duplications, the study suffered from technical inaccuracies in data analysis:

  • Western Blotting: An incorrect Western blot image was used for the analysis of the Bcl-2 protein in Figure S6G.
  • Flow Cytometry: The gating used in Figure S7B was found to be incorrect. In flow cytometry, gating is the process of selecting a subset of cells for further analysis; incorrect gating can lead to misleading results regarding cell population characteristics and states.

Impact on Scientific Integrity

Because these errors spanned five primary figures and two supplemental figures, the authors concluded that they could no longer maintain confidence in the study's original findings. All authors agreed to the retraction, which serves as a corrective measure to remove unreliable data from the scientific literature. This process, while unfortunate, is essential for preventing other researchers from basing their work on flawed premises.

Conclusion and Future Outlook

The retraction of this study highlights the ongoing challenges of maintaining data integrity in high-stakes biomedical research. It underscores the need for journals to adopt more robust, automated image-checking tools and for research institutions to implement stricter oversight of data management. While the potential role of GDF11 in enhancing stem cell therapy remains a valid area for future investigation, such work must be conducted with increased transparency, potentially including the publication of raw, uncropped data to ensure the reproducibility and reliability of the findings.

Summary updated

BibTeX
@inproceedings{zhang2023retraction,
  author = {Chi Zhang and Yinuo Lin and Ke Zhang and Luyang Meng and Xinyang Hu and Jinghai Chen and Wei Zhu and Hong Yu},
  title = {{Retraction Note: GDF11 enhances therapeutic functions of mesenchymal stem cells for angiogenesis}},
  booktitle = {Stem},
  year = {2023},
  doi = {10.1186/s13287-023-03247-1},
}
Figure